News

Hemo Organic Limited will hold a board meeting on Saturday, October 17, 2026, at 4:00 p.m. to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, along with the limited review report thereon.

Hemo Organic Limited informed the BSE Limited that Pratibha Sharma (M. No. A38211) has withdrawn her consent to act as the Company Secretary and Compliance Officer, and consequently, the proposed appointment has not taken effect, with no material reasons cited for the withdrawal.

Hemo Organic Limited on Saturday, October 3, 2026, approved alterations to its Memorandum of Association, including changes to its main objects to cover activities related to diamonds, real estate, and investments, and increased its authorized share capital from Rs 13.45 crore divided into 13.45 million equity shares to Rs 125 crore divided into 12.5 million equity shares. The company also appointed Pratibha Sharma as Company Secretary and Compliance Officer, effective October 3, 2026, while deferring a proposal for fundraising to a future board meeting.

Hemo Organic Limited informed the BSE Limited that the trading window for dealing in Equity Shares of the company by insiders, designated persons, and their immediate relatives will be closed from Thursday, October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026.

Hemo Organic Limited informed the BSE Limited that the meeting of the Board of Directors scheduled for Wednesday, September 23, 2026, has been cancelled due to unavoidable reasons, as previously intimated on September 19, 2026, under Regulation 29 of SEBI (LODR) Regulations, 2015.